Contera Pharma A S Is A Clinical Stage Biotech Company Based In Copenhagendenmarkfocused On Developing Innovative Therapies For Neurological Disordersfounded In 2010It Operates As A Subsidiary Of Bukwang Pharmaceuticalthe Company Is Led By Ceo Thomas Sagerwho Has A Ph Din Neuroscience And Extensive Experience In Drug Discovery Related To The Central Nervous System Contera Pharma Specializes In Creating Novel Treatments For Conditions Such As Parkinsonae S Diseaseits Main Offerings Include A Proprietary Therapy For Managing Dyskinesia And Innovative Formulations Aimed At Addressing Nocturnal Symptoms And Morning Akinesia In Parkinsonae S Patientsthe Company Actively Engages In Partnerships Within The Biotech And Pharmaceutical Industries To Enhance Its Drug Discovery Effortscontera Pharma Has Also Filed Several Patents Related To Drug Delivery Systems And Treatments For Movement Disordersincluding A Notable Pulsatile Drug Delivery System Granted In 2024
